Novartis to reduce workforce by 680 in Product Development - Breaking The News
Download our appPlay StoreApp Store

Novartis to reduce workforce by 680 in Product Development

EPA-EFE/SIMELA PANTZARTZI

Swiss pharmaceutical giant Novartis announced on Tuesday plans to eliminate up to 680 jobs within its development organization, a critical sector responsible for bringing its drugs to market.

The Basel-based company will see around 440 positions cut in Switzerland and up to 240 in the United States over the next two to three years. These job reductions are part of an initiative separate from a more significant restructuring effort, which Novartis previously indicated could affect up to 8,000 of its 78,000 global employees.

Despite these significant reductions, the company aims to reshape its capabilities and access local talent pools, particularly in data science and regulatory specializations, with a keen interest in the United Kingdom.

Related Stocks
Novartis
Related News

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.